Giulia Veronesi, MD
Humanitas Research Hospital, Rozzano, Milan, Italy
Dr. Giulia Veronesi is chief of the Robotic Surgery Unit at the Humanitas Hospital in Milan. She previously headed the screening and lung cancer prevention unit at IEO.
She has led one of the largest European lung cancer screening programs (COSMOS studies) using low dose tomography and MicroRNA testing in high risk individuals and was principal investigator of several lung cancer chemo prevention trials funded by the American National Cancer Institute including the randomized study on inhaled Budesonide compared to placebo for screen detected lung nodules and the randomized study on the protective role of Aspirin in healthy subjects with subsolid lung lesions.
Since 2007 she has developed a robotic surgery program for oncological chest diseases, she is tutor of robotic surgery in Italy and other European countries.
She has designed and co-ordinated an international multicentre randomized trial to compare robotic and manual videotoroscopic surgery for the treatment of lung cancer and has instituted an European working group within the European Society of Thoracic Surgery (ESTS) on Robotics Surgery focused on training and education.
She is a member of several international editorial committees including Lung Cancer, eCancer, Frontiers in Oncology, Annals of Thoracic Surgery and various European and international scientific societies.
She won a prize in 2017 of the Women and Technology Association as a techno-visionary in medicine. She has been invited speaker in over 110 national and international conferences and author of 170 scientific articles with a HI of 33.